Guoxin Ren

1.6k total citations
58 papers, 1.0k citations indexed

About

Guoxin Ren is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guoxin Ren has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 17 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guoxin Ren's work include Head and Neck Cancer Studies (16 papers), Cutaneous Melanoma Detection and Management (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Guoxin Ren is often cited by papers focused on Head and Neck Cancer Studies (16 papers), Cutaneous Melanoma Detection and Management (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Guoxin Ren collaborates with scholars based in China, United States and Cuba. Guoxin Ren's co-authors include Yunteng Wu, Hao Song, Wei Guo, Houyu Ju, Jingzhou Hu, Wei Guo, Wei Guo, Weiya Xia, Nian Zhang and Xiaodong Guo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Guoxin Ren

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoxin Ren China 19 452 349 209 192 172 58 1.0k
Bryan Hassell United States 6 496 1.1× 295 0.8× 29 0.1× 101 0.5× 107 0.6× 9 1.6k
Hélène Burckel France 10 319 0.7× 369 1.1× 19 0.1× 103 0.5× 134 0.8× 26 1.1k
Du Zhi China 21 372 0.8× 563 1.6× 294 1.4× 355 1.8× 193 1.1× 97 1.8k
Yasuyuki Aoyagi Japan 16 395 0.9× 295 0.8× 134 0.6× 186 1.0× 136 0.8× 24 1.3k
Kord Honda United States 14 513 1.1× 177 0.5× 53 0.3× 37 0.2× 89 0.5× 68 899
Jay George United States 11 560 1.2× 502 1.4× 8 0.0× 164 0.9× 80 0.5× 11 1.5k
Bingyan Wu United States 10 407 0.9× 346 1.0× 14 0.1× 81 0.4× 85 0.5× 26 982
Zhenlong Zheng South Korea 21 120 0.3× 262 0.8× 23 0.1× 83 0.4× 83 0.5× 64 1.2k
Xing He China 16 679 1.5× 455 1.3× 37 0.2× 125 0.7× 191 1.1× 35 1.6k
Hsuan‐Chen Liu United States 14 245 0.5× 189 0.5× 19 0.1× 75 0.4× 69 0.4× 23 644

Countries citing papers authored by Guoxin Ren

Since Specialization
Citations

This map shows the geographic impact of Guoxin Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxin Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxin Ren more than expected).

Fields of papers citing papers by Guoxin Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoxin Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxin Ren. The network helps show where Guoxin Ren may publish in the future.

Co-authorship network of co-authors of Guoxin Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Guoxin Ren. A scholar is included among the top collaborators of Guoxin Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoxin Ren. Guoxin Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Wenyi, Zhaoyang Guo, Houyu Ju, et al.. (2025). IL-4-STAT6-induced high Siglec-G/10 expression aggravates the severe immune suppressive tumor microenvironment and impedes the efficacy of immunotherapy in head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 13(6). e011474–e011474. 2 indexed citations
2.
3.
4.
Ju, Houyu, Yunteng Wu, Yang Liu, et al.. (2023). A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma. SHILAP Revista de lepidopterología. 4(4). e312–e312. 7 indexed citations
5.
Wu, Yunteng, et al.. (2022). Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma. Journal of Cancer Research and Clinical Oncology. 149(6). 2293–2300. 5 indexed citations
6.
Song, Hao, Chao Lou, Zhuowei Tian, et al.. (2022). Single-Cell Transcriptome Analysis Reveals Changes of Tumor Immune Microenvironment in Oral Squamous Cell Carcinoma After Chemotherapy. Frontiers in Cell and Developmental Biology. 10. 914120–914120. 21 indexed citations
7.
8.
Liu, Shuli, Yang Wang, Yong Han, et al.. (2020). EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy. Theranostics. 10(23). 10589–10605. 26 indexed citations
9.
Li, Li, et al.. (2020). Validation of Gene Profiles for Analysis of Regional Lymphatic Metastases in Head and Neck Squamous Cell Carcinoma. Frontiers in Molecular Biosciences. 7. 3–3. 3 indexed citations
10.
11.
12.
Song, Hao, et al.. (2015). Periodic acid–Schiff-positive loops and networks as a prognostic factor in oral mucosal melanoma. Melanoma Research. 26(2). 145–152. 8 indexed citations
13.
Wu, Yunteng, et al.. (2014). Head and Neck Rhabdomyosarcoma in Adults. Journal of Craniofacial Surgery. 25(3). 922–925. 23 indexed citations
14.
Wang, Xin, Weiwei Wen, Heming Wu, et al.. (2013). Heparanase expression correlates with poor survival in oral mucosal melanoma. Medical Oncology. 30(3). 633–633. 14 indexed citations
15.
Ren, Guoxin, et al.. (2012). Expression of podoplanin in salivary gland adenoid cystic carcinoma and its association with distant metastasis and clinical outcomes. Molecular Medicine Reports. 6(2). 271–274. 10 indexed citations
16.
Zhong, Yi, Yunteng Wu, Cong Li, et al.. (2012). N‐Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese. Oral Diseases. 18(8). 741–747. 14 indexed citations
17.
Feng, Zhien, Wei Guo, Chenping Zhang, et al.. (2011). CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma. PLoS ONE. 6(10). e26399–e26399. 60 indexed citations
18.
Wang, Xin, Heming Wu, Guoxin Ren, Jie Tang, & Wei Guo. (2011). Primary Oral Mucosal Melanoma: Advocate a Wait-and-See Policy in the Clinically N0 Patient. Journal of Oral and Maxillofacial Surgery. 70(5). 1192–1198. 22 indexed citations
19.
Yang, Xi, Guoxin Ren, Chenping Zhang, et al.. (2010). Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma. BMC Cancer. 10(1). 623–623. 21 indexed citations
20.
Ren, Guoxin, et al.. (2010). Establishment and characterization of a rabbit oral squamous cell carcinoma cell line as a model for in vivo studies. Oral Oncology. 47(1). 39–44. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan Hassell Breakdown of academic impact, for papers by Hélène Burckel Breakdown of academic impact, for papers by Du Zhi Breakdown of academic impact, for papers by Yasuyuki Aoyagi Breakdown of academic impact, for papers by Kord Honda Breakdown of academic impact, for papers by Jay George Breakdown of academic impact, for papers by Bingyan Wu Breakdown of academic impact, for papers by Zhenlong Zheng Breakdown of academic impact, for papers by Xing He Breakdown of academic impact, for papers by Hsuan‐Chen Liu
Rankless by CCL
2026